Short answer
TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on September 4, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation). Additional $1.5 million revolving-credit draw received September 2, 2026.
TuHURA Biosciences, Inc./NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.03 · Creation of a Direct Financial Obligation
- Additional $1.5 million revolving-credit draw received September 2, 2026
- Funds intended for general corporate purposes, increasing liquidity flexibility
- Facility maximum availability of $50 million with maturity on April 21, 2031
- New borrowing adds financial obligations and potential repayment exposure through 2031
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TuHURA Biosciences, Inc./NV 8-K filings
Get the next HURA 8-K as it lands
Follow HURA for push alerts, or ask the research agent what this filing means.